ANN LEEN to Carcinoma, Pancreatic Ductal
This is a "connection" page, showing publications ANN LEEN has written about Carcinoma, Pancreatic Ductal.
Connection Strength
0.886
-
Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trial. Nat Med. 2026 Jan; 32(1):258-269.
Score: 0.811
-
Engineered T cells for pancreatic cancer treatment. HPB (Oxford). 2011 Sep; 13(9):643-50.
Score: 0.074